NCT04713969View on ClinicalTrials.gov

Neuro-immune Interactions and PPI

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2021

Primary Completion Date

January 10, 2024

Study Completion Date

September 23, 2024

Conditions
Functional Dyspepsia
Interventions
DRUG

Pantoprazole 40mg

Pantoprazole 40mg twice daily

Trial Locations (1)

3000

KU Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT04713969 - Neuro-immune Interactions and PPI | Biotech Hunter | Biotech Hunter